Viewing Study NCT04316169


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2026-01-01 @ 10:38 AM
Study NCT ID: NCT04316169
Status: WITHDRAWN
Last Update Posted: 2022-12-23
First Post: 2020-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Sponsor: Medical College of Wisconsin
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None Advanced Breast Cancer View
Keywords: